Real Chemistry Continuation Fund (New Mountain Capital)

In April 2025, New Mountain Capital formed a single-asset continuation vehicle to acquire portfolio company Real Chemistry from New Mountain Partners V, L.P.

Real Chemistry is a global health innovation company focused on delivering analytics-driven, digital-first solutions to the healthcare industry, spanning communications, advertising, and medical capabilities supported by proprietary technology and data analytics.